Care Pathway for Patients Undergoing VATS Lobectomy or Segmentectomy

NCT03024294 | Unknown

• 1 other identifier: 2016P002308
• Study Type: interventional
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this study is to create a unified SOP for care of subjects undergoing VATS lobectomy and segmentectomy by members of the Division of Thoracic Surgery. Other academic centers have created standardized algorithms for the care of their subjects and this enables the centers to determine which subjects can be placed on an accelerated pathway to discharge and which cannot. Some of these SOPS dictate uniform treatment algorithms with reduction in what may be unnecessary tests to simplify patient care and likely accelerate them towards safe and more timely discharge from the hospital.

Conditions

VATS Lobectomy; VATS Segmentectomy; Care Pathway; Lung Nodule

Outcome Measures

Primary Outcomes (2)

• The primary objective is to evaluate feasibility of this SOP in two phases. The primary objective of phase 1 is to determine the POD 3 rate, defined as proportion of patients who are discharged by midnight on POD 3.

  From date of consent until midnight of post op day 3

• The primary objective of phase II is to further evaluate this SOP. The study team will also have the opportunity to refine and fine tune this SOP between phase I and phase II.

  From date of consent until midnight of post op day 3

Study Arms (1)

Patients undergoing VATS lobectomy or segmentectomy

OTHER

Patients undergoing VATS lobectomy or segmentectomy performed by one of the surgeons in the Division of Thoracic Surgery who are then placed on this specific post-operative care pathway to determine the rate of discharge of these patients by post-operative day (POD) three.

Other: Post-operative care pathway for patients undergoing VATS lobectomy or segmentectomy

Interventions

Post-operative care pathway for patients undergoing VATS lobectomy or segmentectomy OTHER

To place participants on this specific post-operative care pathway upon the completion of their VATS surgery to determine the discharge rate by midnight on post-operative day (POD) three.

Patients undergoing VATS lobectomy or segmentectomy

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Male and female subjects
• Age ≥ 18 years
• Subjects planned to undergo a VATS lobectomy or segmentectomy procedure for lung nodules

You may not qualify if:

• Subjects who cannot undergo VATS surgery
• Subjects undergoing any kind of resection in addition to VATS Lobectomy or Segmentectomy

Sponsors & Collaborators

• Brigham and Women's Hospital: lead

Study Sites (1)

Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States

Location

MeSH Terms

Interventions

Mastectomy, Segmental

Intervention Hierarchy (Ancestors)

Mastectomy; Surgical Procedures, Operative

Study Officials

• Scott Swanson, MD

  Brigham and Women's Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: January 6, 2017
• First Posted: January 18, 2017
• Study Start: January 1, 2017
• Primary Completion: December 1, 2019
• Study Completion: December 1, 2019
• Last Updated: July 16, 2018

Record last verified: 2018-07

Locations

US (1)